Persistent COVID-19 symptoms in a community study of 606,434 people in England.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2022 – Oct 2023Where it's discussed
-
X / Twitter112 posts
-
News52 articles
-
Blogs5 articles
-
YouTube4 videos
-
Facebook2 posts
AI synopsis
What people are saying
The overall tone demonstrates strong interest and engagement, exemplified by mentions of specific data like '37.7% experienced symptoms at 12 weeks', and phrases such as 'very important', highlighting the significance of long COVID research. The words express concern and recognition of the ongoing health issues, contributing to the moderate agreement and impact scores.
Most discussions acknowledge the significance of the study and its findings, showing general support and recognition of long COVID prevalence, though some tone indicates ongoing concern rather than full endorsement.
The messages display high interest, with many referencing specific statistics and emphasizing the ongoing nature of symptoms, reflecting engagement with the research's implications.
Posts include references to percentages, comparisons over time, and calls for further understanding, indicating active engagement and curiosity.
The discussions underline the importance of the findings on public health understanding, especially regarding persistent symptoms, showing a perceived moderate to high impact of the study.
Abstract in brief
- The study investigates long COVID symptoms in a large sample of over 600,000 people in England, finding that about 37.7% of individuals experienced symptoms lasting at least 12 weeks, with this percentage decreasing to 21.6% in later data.
- Factors such as being female, older age, obesity, smoking, healthcare worker status, hospitalization, deprivation, and COVID-19 infection increase the likelihood of persistent symptoms, while Asian ethnicity is linked to a lower risk.
- Clustering analysis revealed a group of individuals mainly experiencing respiratory symptoms, highlighting the complexity of long COVID and emphasizing the need for ongoing healthcare support for affected patients.
Top posts
Most liked on X and BlueskyOpen Access: About 20% still symptomatic at 12 weeks. Whitaker, M., Elliott, J., Chadeau-Hyam, M. et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun 13, 1957 (2022). https://t.co/0swDdt0BtO
@angryhacademic https://t.co/F4II5LGGDh Persistent COVID-19 symptoms in a community study of 606,434 people in England https://t.co/yRcO82Ip7B https://t.co/lWpcXRHHpC
@Vadeboncoeur_Al @pierrotcharette Cette étude donne une idée générale. https://t.co/3THs2rHPmb Un fort % s’améliore dans les 3 premiers mois. Bcp plus lent ensuite. Il y a qq autres études, mais je suis à l’extérieur et je ne les ai pas sous la main… Il reste cependant trop de symptomatiques depuis mars 2020.
Références en rafale! 3. COVID longue OMS : https://t.co/V4hB8l4h2P Évolution : https://t.co/3THs2rHPmb 16/x https://t.co/NX8QySA4tV
@Vadeboncoeur_Al ✅ @DonaldVinh Et:
All mentions
Understanding Long COVID: Key Findings from a Large Community Study in England
This study investigates long COVID symptoms in over 600,000 people in England, finding that 37.7% experienced symptoms lasting at least 12 weeks. Factors like age, gender, obesity, and healthcare worker status influence…
Analyzing Long COVID Symptoms in a Large English Community Study
This study investigates long COVID symptoms in over 600,000 people in England, finding that 37.7% experienced symptoms lasting at least 12 weeks. Factors like age, gender, obesity, and occupational exposure increase…
Long COVID Symptoms in England Community Study of Over 600,000 People
This study investigates long COVID symptoms in a large sample of over 600,000 individuals in England, finding that about 37.7% experienced symptoms lasting at least 12 weeks, with certain factors increasing the risk.
Long COVID symptoms in England: A community study of over 600,000 people
This study investigates long COVID symptoms in a large sample of over 600,000 people in England, finding that about 37.7% experienced symptoms lasting at least 12 weeks, with factors like age, gender, obesity, and…
@MNHR_Labo “A slower decline in symptom prevalence is observed after 12 weeks in both sexes.” Persistent COVID-19 symptoms in a community study of 606,434 people in England. https://t.co/5mgWI9bBDN (Accessed 25 June 2023) (2/2) https://t.co/UFgZqxIP9l
"the proportion of people with COVID-19 who still reported...symptoms at 12 weeks after symptom onset...[was] 37.7%[rounds 3–5]...and 17.5%[round 6]" Persistent COVID-19 symptoms in a community study of 606,434 people in England. https://t.co/5mgWI9bBDN (Accessed 17 June 2023) https://t.co/QXGxrXmTNV
RT @renesugar: @angryhacademic https://t.co/F4II5LGGDh Persistent COVID-19 symptoms in a community study of 606,434 people in England htt…
@angryhacademic https://t.co/F4II5LGGDh Persistent COVID-19 symptoms in a community study of 606,434 people in England https://t.co/yRcO82Ip7B https://t.co/lWpcXRHHpC
RT @sandralopezleon:
@Vadeboncoeur_Al @pierrotcharette Cette étude donne une idée générale. https://t.co/3THs2rHPmb Un fort % s’améliore dans les 3 premiers mois. Bcp plus lent ensuite. Il y a qq autres études, mais je suis à l’extérieur et je ne les ai pas sous la main… Il reste cependant trop de symptomatiques depuis mars 2020.
Références en rafale! 3. COVID longue OMS : https://t.co/V4hB8l4h2P Évolution : https://t.co/3THs2rHPmb 16/x https://t.co/NX8QySA4tV
@Vadeboncoeur_Al ✅ @DonaldVinh Et:
RT @sandralopezleon:
RT @sandralopezleon:
Coronavirus: Persistent COVID-19 symptoms in a community study of 606,434 people in England – PubMed https://t.co/zIp9jAdkaf
The symptoms lists in the supplementary. I think it might be useful to include a "flu-like illness" or "malaise" symptoms as a possible sign of ongoing inflammation/cytokine activity. https://t.co/O4NkXqyfNR
Open Access: About 20% still symptomatic at 12 weeks. Whitaker, M., Elliott, J., Chadeau-Hyam, M. et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun 13, 1957 (2022). https://t.co/0swDdt0BtO
Nouvelle étude d’envergure sur le #covidLong en Angleterre Persistent COVID-19 symptoms in a community study of 606,434 people in England | Nature Communications #apresJ20 https://t.co/UfKAaYcuew
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @HAS_veille: Persistent COVID-19 symptoms in a community study of 606,434 people in England | Nature Communications https://t.co/r8Z0LNs…
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
Persistent COVID-19 symptoms in a community study of 606,434 people in England | Nature Communications https://t.co/r8Z0LNsgU7
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
RT @sandralopezleon:
Persistent COVID-19 symptoms in a community study of 606,434 people in England https://t.co/okQVo0yyI2
RT @painphysio: Persistent COVID-19 symptoms in a community study of 606,434 people in England https://t.co/TteDJcigtP #thepaincoach #Lon…
Persistent COVID-19 symptoms in a community study of 606,434 people in England https://t.co/TteDJcigtP #thepaincoach #LongCovid https://t.co/FTemZHTa1K
PASC data from the REACT-2 study. 37.7% of respondents had ≥1 and 17.5% ≥3 persistent symptoms at 12 weeks post-onset. 10X background prevalence in PCR-neg respondents. Persistent COVID-19 symptoms in a community study of 606,434 people in England https://t.co/htI4Yo6LKn
Persistent COVID-19 symptoms in a community study of 606,434 people in England https://t.co/dZezBw685B #LongCovid #pwLC
Persistent COVID-19 symptoms in a community study of 606,434 people in England | Nature Communications https://t.co/kPIZ8LoQBC
Persistent COVID-19 symptoms in a community study of 606,434 people in England @NatureComms https://t.co/5ZFn8YBGLq "While many #LongCovid studies so far have focused on hospitalised #COVID19 cases here we report data from random community-based samples of the pop in England."
#ITDidntHaveToBeThisWay Persistent COVID-19 symptoms in a community study of 606,434 people in England | Nature Communications https://t.co/2OHk6zY51S